CVS HEALTH Corp — Director's Dealing 2012

Mar 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-03-14

Reporting Person: BANKS EDWIN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-14	Common Stock	M	46856	$13.41	Acquired	70043	Direct
2012-03-14	Common Stock	M	46849	$9.17	Acquired	116892	Direct
2012-03-14	Common Stock	S	46856	$45.13	Disposed	70036	Direct
2012-03-14	Common Stock	S	46849	$45.17	Disposed	23187	Direct
2012-03-15	Common Stock	M	33726	$27.12	Acquired	56913	Direct
2012-03-15	Common Stock	M	33739	$20.23	Acquired	90652	Direct
2012-03-15	Common Stock	S	33726	$45.11	Disposed	56926	Direct
2012-03-15	Common Stock	S	33739	$45.11	Disposed	23187	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-14	Stock Option	$13.41	M	46856	Disposed	2014-01-02	Common Stock (46856)	Direct
2012-03-14	Stock Option	$9.17	M	46849	Disposed	2013-02-25	Common Stock (46849)	Direct
2012-03-15	Stock Option	$27.12	M	33726	Disposed	2016-03-01	Common Stock (33726)	Direct
2012-03-15	Stock Option	$20.23	M	33739	Disposed	2015-03-01	Common Stock (33739)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Share Credits	$0		Common Stock (22924.6292)	22924.6292	Direct

Footnotes

F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.12 and $45.16 per share.

F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.16 and $45.19 per share.

F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share.

F4: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share.

F5: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

F6: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election.